Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.77B | $2.21B | $2.97B | $2.84B | $2.17B | $2.25B | $2.78B | $3.09B | $3.27B | $3.36B |
| Revenue growth | — | 25.1% | 34.2% | -4.5% | -23.5% | 3.5% | 24.0% | 11.0% | 5.6% | 3.0% |
| Operating income | $247M | $93.6M | $155M | $242M | -$421M | -$258M | $193M | $335M | $399M | $496M |
| Operating margin | 14.0% | 4.2% | 5.2% | 8.5% | -19.4% | -11.5% | 6.9% | 10.8% | 12.2% | 14.8% |
| Net income | $141M | $313M | $78.5M | $142M | -$273M | -$247M | $122M | $223M | $287M | $355M |
| Net margin | 8.0% | 14.1% | 2.6% | 5.0% | -12.6% | -11.0% | 4.4% | 7.2% | 8.8% | 10.5% |
| EPS (diluted) | $2.62 | $5.62 | $1.31 | $2.37 | -$4.55 | -$4.11 | $2.03 | $3.72 | $4.91 | $6.33 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $416M | $353M | $347M | $512M | $445M | $322M | $294M | $540M | $756M | $670M |
| Capital expenditures | $231M | $177M | $302M | $248M | $148M | $98.0M | $173M | $402M | $343M | $264M |
| Free cash flow | $185M | $176M | $45.1M | $264M | $297M | $224M | $122M | $138M | $414M | $406M |
| Share buybacks | $1.83M | $0.00 | $776K | $0.00 | $0.00 | $0.00 | $22.9M | $113M | $175M | $354M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.63M | $20.1M | $7.80M | $24.7M | $80.3M | $34.8M | $80.6M | $32.6M | $74.4M | $78.8M |
| Total assets | $4.29B | $5.13B | $5.87B | $6.08B | $5.92B | $5.40B | $5.55B | $5.72B | $5.85B | $6.01B |
| Long-term debt | $723M | $992M | $1.41B | $1.37B | $1.47B | $1.16B | $1.08B | $1.01B | $867M | $912M |
| Shareholders' equity | $2.41B | $3.11B | $3.21B | $3.37B | $3.08B | $2.89B | $3.04B | $3.19B | $3.35B | $3.38B |
| Retained earnings | $2.34B | $2.65B | $2.72B | $2.87B | $2.59B | $2.35B | $2.47B | $2.69B | $2.98B | $3.33B |
| Shares (wtd avg diluted) | 53.5M | 55.4M | 59.7M | 59.9B | 59.9M | 60.1M | 60.3M | 59.9M | 58.4M | 56.0M |
Every figure is extracted from KIRBY CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.